BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 26434368)

  • 21. Gingipains: Critical Factors in the Development of Aspiration Pneumonia Caused by Porphyromonas gingivalis.
    Benedyk M; Mydel PM; Delaleu N; Płaza K; Gawron K; Milewska A; Maresz K; Koziel J; Pyrc K; Potempa J
    J Innate Immun; 2016; 8(2):185-98. PubMed ID: 26613585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The roles of RgpB and Kgp in late onset gingipain activity in the vimA-defective mutant of Porphyromonas gingivalis W83.
    Dou Y; Robles A; Roy F; Aruni AW; Sandberg L; Nothnagel E; Fletcher HM
    Mol Oral Microbiol; 2015 Oct; 30(5):347-60. PubMed ID: 25858089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gingipain-dependent degradation of mammalian target of rapamycin pathway proteins by the periodontal pathogen Porphyromonas gingivalis during invasion.
    Stafford P; Higham J; Pinnock A; Murdoch C; Douglas CW; Stafford GP; Lambert DW
    Mol Oral Microbiol; 2013 Oct; 28(5):366-78. PubMed ID: 23714361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adhesion of Porphyromonas gingivalis and Tannerella forsythia to dentin and titanium with sandblasted and acid etched surface coated with serum and serum proteins - An in vitro study.
    Eick S; Kindblom C; Mizgalska D; Magdoń A; Jurczyk K; Sculean A; Stavropoulos A
    Arch Oral Biol; 2017 Mar; 75():81-88. PubMed ID: 27825675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of inflammatory responses of human gingival fibroblasts by gingipains from Porphyromonas gingivalis.
    Palm E; Khalaf H; Bengtsson T
    Mol Oral Microbiol; 2015 Feb; 30(1):74-85. PubMed ID: 25055828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gingipains as candidate antigens for Porphyromonas gingivalis vaccine.
    Nakagawa T; Saito A; Hosaka Y; Ishihara K
    Keio J Med; 2003 Sep; 52(3):158-62. PubMed ID: 14529148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A role for gingipains in cellular responses and bacterial survival in Porphyromonas gingivalis-infected cells.
    Kadowaki T; Takii R; Yamatake K; Kawakubo T; Tsukuba T; Yamamoto K
    Front Biosci; 2007 Sep; 12():4800-9. PubMed ID: 17569610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of gingipain-specific I-A(b) -restricted CD4+ T cells following mucosal colonization with Porphyromonas gingivalis in C57BL/6 mice.
    Bittner-Eddy PD; Fischer LA; Costalonga M
    Mol Oral Microbiol; 2013 Dec; 28(6):452-66. PubMed ID: 23945018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of RgpA, RgpB, and Kgp proteinases in virulence of Porphyromonas gingivalis W50 in a murine lesion model.
    O'Brien-Simpson NM; Paolini RA; Hoffmann B; Slakeski N; Dashper SG; Reynolds EC
    Infect Immun; 2001 Dec; 69(12):7527-34. PubMed ID: 11705929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteolytic Activity-Independent Activation of the Immune Response by Gingipains from Porphyromonas gingivalis.
    Ciaston I; Budziaszek J; Satala D; Potempa B; Fuchs A; Rapala-Kozik M; Mizgalska D; Dobosz E; Lamont RJ; Potempa J; Koziel J
    mBio; 2022 Jun; 13(3):e0378721. PubMed ID: 35491845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction and characterization of arginine-specific cysteine proteinase (Arg-gingipain)-deficient mutants of Porphyromonas gingivalis. Evidence for significant contribution of Arg-gingipain to virulence.
    Nakayama K; Kadowaki T; Okamoto K; Yamamoto K
    J Biol Chem; 1995 Oct; 270(40):23619-26. PubMed ID: 7559528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of Porphyromonas gingivalis gingipains in platelet activation and innate immune modulation.
    Klarström Engström K; Khalaf H; Kälvegren H; Bengtsson T
    Mol Oral Microbiol; 2015 Feb; 30(1):62-73. PubMed ID: 25043711
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Nakayama M; Naito M; Omori K; Ono S; Nakayama K; Ohara N
    J Immunol; 2022 Mar; 208(5):1146-1154. PubMed ID: 35110422
    [No Abstract]   [Full Text] [Related]  

  • 34. Cleavage of protease-activated receptors on an immortalized oral epithelial cell line by Porphyromonas gingivalis gingipains.
    Giacaman RA; Asrani AC; Ross KF; Herzberg MC
    Microbiology (Reading); 2009 Oct; 155(Pt 10):3238-3246. PubMed ID: 19608609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gingival fibroblast responsiveness is differentially affected by Porphyromonas gingivalis: implications for the pathogenesis of periodontitis.
    Scheres N; Crielaard W
    Mol Oral Microbiol; 2013 Jun; 28(3):204-18. PubMed ID: 23279858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a novel Porphyromonas gingivalis outer membrane protein, PG534, required for the production of active gingipains.
    Saiki K; Konishi K
    FEMS Microbiol Lett; 2010 Sep; 310(2):168-74. PubMed ID: 20695897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural insights unravel the zymogenic mechanism of the virulence factor gingipain K from
    Pomowski A; Usón I; Nowakowska Z; Veillard F; Sztukowska MN; Guevara T; Goulas T; Mizgalska D; Nowak M; Potempa B; Huntington JA; Potempa J; Gomis-Rüth FX
    J Biol Chem; 2017 Apr; 292(14):5724-5735. PubMed ID: 28196869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Porphyromonas gingivalis and Treponema denticola synergistic polymicrobial biofilm development.
    Zhu Y; Dashper SG; Chen YY; Crawford S; Slakeski N; Reynolds EC
    PLoS One; 2013; 8(8):e71727. PubMed ID: 23990979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional characteristics of antibodies induced by Arg-gingipain (HRgpA) and Lys-gingipain (Kgp) from Porphyromonas gingivalis.
    Nakagawa T; Sims T; Fan Q; Potempa J; Travis J; Houston L; Page RC
    Oral Microbiol Immunol; 2001 Aug; 16(4):202-11. PubMed ID: 11442844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triggering NETosis via protease-activated receptor (PAR)-2 signaling as a mechanism of hijacking neutrophils function for pathogen benefits.
    Bryzek D; Ciaston I; Dobosz E; Gasiorek A; Makarska A; Sarna M; Eick S; Puklo M; Lech M; Potempa B; Potempa J; Koziel J
    PLoS Pathog; 2019 May; 15(5):e1007773. PubMed ID: 31107907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.